MetaCap

Lite Strategy (LITS) vs Rockwell Medical (RMTI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Rockwell Medical (RMTI) has outperformed Lite Strategy (LITS) over the past year, losing 34.6% versus a loss of 52.8%. Over five years, RMTI leads with a -88.0% price change compared with -98.5% for LITS. Lite Strategy is the larger company by market cap ($24.0 million vs $23.1 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LITS-52.79%RMTI-34.61%
+46%-7%-61%
Nov 21, 20251 yearNov 20, 2026
LITS-98.56%RMTI-88.98%
+9%-48%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LITS versus RMTI key metrics
MetricLITSRMTI
Share price$0.8026$5.82
Market cap$23.99M$23.12M
1-day change-4.03%-7.03%
YTD return-39.20%-29.88%
1-year return-52.79%-34.61%
5-year return-98.46%-87.98%
Forward P/E—83.14
EPS (TTM)$-1.38$-1.43
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$69.26M
Revenue growth (YoY)—-31.76%
Net income (latest FY)$-71.15M$-5.31M
Gross margin—16.89%
Operating margin—-6.77%
Net margin—-7.67%
52-week high$1.99$12.90
52-week low$0.69$4.89
Distance from 52-week high-59.67%-54.88%
Analyst consensus—none
Avg. price target upside—+243.64%
Average volume524.33K25.91K
Shares outstanding29.88M3.97M
Employees5157
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RMTI has outperformed LITS by 18.2 percentage points over the past year.

About Lite Strategy

LITS stock →

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About Rockwell Medical

RMTI stock →

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.

Health Care · Biotechnology: Pharmaceutical Preparations · 157 employees

LITS vs RMTI FAQ

Which is bigger, Lite Strategy or Rockwell Medical?

Lite Strategy (LITS) is larger, with a market capitalization of $23.99M compared with $23.12M for Rockwell Medical (RMTI).

Which stock has performed better over the past year, LITS or RMTI?

RMTI returned -34.61% over the past 12 months, compared with -52.79% for LITS (price return, excluding dividends). Past performance does not predict future results.

Are Lite Strategy and Rockwell Medical in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons